A chimeric antigen receptor-based cellular safeguard mechanism for selective in vivo depletion of engineered T cellsMortimer Svec(Institute of Medical Microbiology and Hygiene), Dirk H. Busch(Technical University of Munich)Frontiers in ImmunologyJanuary 11, 202410.3389/fimmu.2023.1268698Cited by 3SaveCiteExport RISWatch citationsRelated PapersMHC Multimer-Guided and Cell Culture-Independent Isolation of Functional T Cell Receptors from Single Cells Facilitates TCR Identification for Immunotherapy|PLoS ONE|2013|46Optimizing CD34+ cell doses for large-scale translational, single donor humanized mouse experiments|Research Square|2025|1